VRAYQ

Healthcare Medical Devices

ViewRay Systems, Inc.

$0.00
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
18,340.204
Avg Volume
0
EPS
-$6.00
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%

Valuation

Forward P/E
-0.00
P/B Ratio
0.00
P/S Ratio
0.00
EV/EBITDA
-0.04
EV/Revenue
0.04

Margins

Gross Margin 8.0%
Operating Margin (131.5%)
Net Margin (104.3%)
EBITDA Margin (97.0%)

Growth & Returns

Revenue Growth (YoY)
19.4%
Return on Equity
(108.9%)
Return on Assets
(25.3%)

Liquidity & Leverage

Current Ratio
1.16
Quick Ratio
0.77
Debt / Equity
1.54
Total Cash
81.29M
Total Debt
85.13M

About

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.

viewraysystems.com